The Clorox Company (NYSE:CLX) Holdings Lessened by Parsifal Capital Management LP

Parsifal Capital Management LP trimmed its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 25.4% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 693,788 shares of the company’s stock after selling 236,071 shares during the quarter. Clorox makes up 7.7% of Parsifal Capital Management LP’s holdings, making the stock its 5th biggest holding. Parsifal Capital Management LP’s holdings in Clorox were worth $113,025,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the business. Prospera Private Wealth LLC bought a new position in Clorox during the 3rd quarter valued at about $27,000. Innealta Capital LLC bought a new position in Clorox during the 2nd quarter valued at about $30,000. Trifecta Capital Advisors LLC grew its holdings in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after purchasing an additional 130 shares during the last quarter. Quarry LP grew its holdings in Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the last quarter. Finally, Family Firm Inc. bought a new position in Clorox during the 2nd quarter valued at about $31,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. JPMorgan Chase & Co. upped their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research note on Friday, October 11th. DA Davidson upped their price target on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. BNP Paribas raised shares of Clorox to a “strong sell” rating in a research report on Friday, September 6th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and upped their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Finally, Evercore ISI lowered their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Five analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, Clorox has a consensus rating of “Hold” and an average price target of $155.00.

Get Our Latest Report on Clorox

Insider Transactions at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.57% of the company’s stock.

Clorox Stock Up 0.3 %

CLX opened at $167.08 on Wednesday. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.35. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The company has a fifty day moving average of $163.18 and a two-hundred day moving average of $149.90. The stock has a market capitalization of $20.68 billion, a price-to-earnings ratio of 58.22, a PEG ratio of 3.08 and a beta of 0.42.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the previous year, the company earned $0.49 earnings per share. The firm’s revenue for the quarter was up 27.0% on a year-over-year basis. On average, research analysts expect that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.92%. Clorox’s dividend payout ratio is currently 170.03%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.